Literature DB >> 18771395

Dysautonomia and Clinical Outcome in Vegetative State.

Giuliano Dolce1, Maria Quintieri1, Elio Leto1, Michele Milano1, Antonio Pileggi1, Vincenzo Lagani2, Loris Pignolo2.   

Abstract

A dramatic disorder tentatively attributed to diencephalic-hypothalamic damage or dysfunction, dysautonomia, affects recovery from brain injury. Its incidence, correlation with etiology, and relevance as a predictor of outcome were retrospectively surveyed in 333 patients in vegetative state (VS) for more than 2 weeks at admission. Outcome was assessed according to the Glasgow Outcome Scale. Data were treated statistically by multi-variate analyses. Dysautonomia occurred in 26.1% of patients, with greater incidence among post-traumatic (31.9%) than non-traumatic (15.8%) patients. Outcome was worse among non-traumatic than post-traumatic patients irrespective of dysautonomia, and worst among non-traumatic patients with dysautonomia. Dysautonomia proved common among patients in VS (with incidence depending on etiology and age) and influenced the patients' outcome through mechanisms still to be defined, but conceivably mediated by diencephalic-hypothalamic unbalance.

Entities:  

Keywords:  dysautonomia; outcome; vegetative state

Mesh:

Year:  2021        PMID: 18771395     DOI: 10.1089/neu.2008.0536

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  9 in total

Review 1.  Autonomic dysfunction in the neurological intensive care unit.

Authors:  Max J Hilz; Mao Liu; Sankanika Roy; Ruihao Wang
Journal:  Clin Auton Res       Date:  2018-07-18       Impact factor: 4.435

2.  Readmission to an Acute Care Hospital During Inpatient Rehabilitation for Traumatic Brain Injury.

Authors:  Flora M Hammond; Susan D Horn; Randall J Smout; Cynthia L Beaulieu; Ryan S Barrett; David K Ryser; Teri Sommerfeld
Journal:  Arch Phys Med Rehabil       Date:  2015-08       Impact factor: 3.966

Review 3.  Paroxysmal sympathetic hyperactivity after acute brain injury.

Authors:  H Alex Choi; Sang-Beom Jeon; Sophie Samuel; Teresa Allison; Kiwon Lee
Journal:  Curr Neurol Neurosci Rep       Date:  2013-08       Impact factor: 5.081

4.  Paroxysmal sympathetic hyperactivity in neurological critical care.

Authors:  Rajesh Verma; Prithvi Giri; Imran Rizvi
Journal:  Indian J Crit Care Med       Date:  2015-01

5.  The preventive effect of dexmedetomidine on paroxysmal sympathetic hyperactivity in severe traumatic brain injury patients who have undergone surgery: a retrospective study.

Authors:  Qilin Tang; Xiang Wu; Weiji Weng; Hongpeng Li; Junfeng Feng; Qing Mao; Guoyi Gao; Jiyao Jiang
Journal:  PeerJ       Date:  2017-02-15       Impact factor: 2.984

6.  Intrathecal baclofen in paroxysmal sympathetic hyperactivity: Impact on oral treatment.

Authors:  Elke Pucks-Faes; Gabriel Hitzenberger; Heinrich Matzak; Giulio Verrienti; Robert Schauer; Leopold Saltuari
Journal:  Brain Behav       Date:  2018-09-28       Impact factor: 2.708

7.  Paroxysmal Sympathetic Hyperactivity in Severe Anti-N-Methyl-d-Aspartate Receptor Encephalitis: A Single Center Retrospective Observational Study.

Authors:  Dongmei Wang; Shuang Su; Miaoqin Tan; Yongming Wu; Shengnan Wang
Journal:  Front Immunol       Date:  2021-04-12       Impact factor: 7.561

8.  Characteristics and Outcomes of Paroxysmal Sympathetic Hyperactivity in Anti-NMDAR Encephalitis.

Authors:  Zhongyun Chen; Yan Zhang; Xiaowen Wu; Huijin Huang; Weibi Chen; Yingying Su
Journal:  Front Immunol       Date:  2022-04-06       Impact factor: 8.786

9.  Paroxysmal sympathetic hyperactivity in brainstem-compressing huge benign tumors: clinical experiences and literature review.

Authors:  Seungjoo Lee; Go Woon Jun; Sang Beom Jeon; Chang Jin Kim; Jeong Hoon Kim
Journal:  Springerplus       Date:  2016-03-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.